Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J Racial Ethn Health Disparities. 2016 Dec 7;4(6):1147–1158. doi: 10.1007/s40615-016-0320-2

Fig. 1.

Fig. 1

Monthly uptake of new hepatitis C drugs by race by the presence of cirrhosis in Medicare in 2014. Monthly uptake rates were computed as the percent of chronic hepatitis C patients who had the first fill of new hepatitis C virus (HCV) drugs in the month among those who had not received any new HCV drug until that month. After filling the first prescription of a new HCV drug, patients were excluded from calculating uptake rates in the following months